ACE2 and COVID-19: Therefore, adequate glycemic control indiabetic patients is warranted as it increased the antibody response afterCOVID-19 vaccination, decreased the overexpression of ACE2 in cardiomyocytes, andreduced the risk of severe COVID-19 as well as long COVID.